Exane Derivatives

SEC CIK: 0001623883
Latest filing: Jul 12, 2022

SEC filings (opens in a new tab)

MIRM holding history

Mirum Pharmaceuticals, Inc. in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MIRM overview All 13F holders of MIRM Full Q2 2022 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of MIRM by Exane Derivatives, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−8,999−100.0%	Sold out	Holders
Q3 2021	8,999	$179.3K	<0.1%	+373+4.3%	Added	Holders
Q2 2021	8,626	$138.2K	<0.1%	+8,626	New	Holders